Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.74)
# 2,074
Out of 5,044 analysts
3
Total ratings
66.67%
Success rate
22.97%
Average return

Stocks Rated by Matthew Hewitt

Certara
Sep 29, 2025
Initiates: Buy
Price Target: $16
Current: $12.13
Upside: +31.90%
Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $6.88
Upside: +45.45%